Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Harvard Business School

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,821,927

« Back to Dashboard

Which drugs does patent 8,821,927 protect, and when does it expire?

Patent 8,821,927 protects TYKERB and is included in one NDA. There has been one Paragraph IV challenge on Tykerb.

This patent has twenty-four patent family members in twenty-seven countries.

Summary for Patent: 8,821,927

Title:Pharmaceutical composition
Abstract: Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
Inventor(s): Carter; Barry Howard (Kinston, NC), Campbell; Dwayne A (Durham, NC)
Assignee: SmithKline Beecham (Cork) Limited (Carrigaline, County Cork, IE)
Application Number:11/911,843
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpTYKERBlapatinib ditosylateTABLET;ORAL022059-001Mar 13, 2007RXYesYes► Subscribe► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,821,927

PCT Information
PCT FiledApril 18, 2006PCT Application Number:PCT/US2006/014447
PCT Publication Date:October 26, 2006PCT Publication Number: WO2006/113649

International Patent Family for Patent: 8,821,927

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China101203211► Subscribe
Cyprus1118179► Subscribe
Denmark1871347► Subscribe
Eurasian Patent Organization200702253► Subscribe
European Patent Office1871347► Subscribe
Spain2601503► Subscribe
CroatiaP20161429► Subscribe
HungaryE030982► Subscribe
Israel186336► Subscribe
Japan2008536931► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: